Bio-Medical Applications of New Jersey, INC.
Bio-Medical Applications of New Jersey, INC. was paid $8.81M by Medicaid between Jan 2018 and Nov 2024, across 53 billing codes. Its largest line is 90935, Hemodialysis procedure with single evaluation by a physician — 66% of everything it billed.
NEWARK, NJ 07103
Next to other End-Stage Renal Disease (ESRD) Treatment Clinic/Center providers in New Jersey
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,547 | $1.50M | |
| 2019 | 23,274 | $1.66M | |
| 2020 | 34,086 | $1.34M | |
| 2021 | 33,646 | $1.12M | |
| 2022 | 57,391 | $1.15M | |
| 2023 | 70,775 | $1.23M | |
| 2024incomplete | 49,114 | $799K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90935 | Hemodialysis procedure with single evaluation by a physician | 66% | 29,992 | 2,437 | $5.80M |
| 90999 | Dialysis (unlisted procedure)Unlisted dialysis procedure, inpatient or outpatient | 19% | 26,658 | 2,039 | $1.72M |
| A4657 | Syringe, with or without needle, each | 4.4% | 60,956 | 3,551 | $391K |
| 85018 | 1.6% | 13,780 | 3,806 | $138K | |
| 84100 | <1% | 5,500 | 3,290 | $77K | |
| 84520 | <1% | 6,589 | 3,782 | $71K | |
| 82310 | <1% | 4,696 | 3,145 | $66K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 10,724 | 1,978 | $55K |
| 83540 | <1% | 4,534 | 3,769 | $42K | |
| 84460 | <1% | 4,505 | 3,743 | $42K | |
| 84450 | <1% | 4,501 | 3,738 | $42K | |
| 84155 | <1% | 4,480 | 3,733 | $41K |
41 more codes
| 84466 | <1% | 1,367 | $41K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | <1% | 3,925 | $26K |
| 80051 | <1% | 2,631 | $26K | |
| 82565 | <1% | 2,917 | $25K | |
| 82040 | <1% | 2,970 | $25K | |
| J1270 | Injection, doxercalciferol, 1 mcg | <1% | 9,541 | $23K |
| 85027 | <1% | 3,907 | $22K | |
| 83970 | <1% | 3,804 | $22K | |
| 87340 | <1% | 1,947 | $21K | |
| 82728 | <1% | 2,053 | $17K | |
| 86706 | <1% | 1,902 | $16K | |
| 83735 | <1% | 1,399 | $14K | |
| 84075 | <1% | 1,397 | $14K | |
| 80069 | <1% | 1,410 | $12K | |
| 82108 | <1% | 393 | $5K | |
| 82607 | <1% | 303 | $5K | |
| 82746 | <1% | 329 | $5K | |
| 86803 | <1% | 391 | $2K | |
| 85046 | <1% | 71 | $732.82 | |
| G0008 | Administration of influenza virus vaccine | <1% | 223 | $597.36 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 28,636 | $569.60 |
| 83550 | <1% | 2,793 | $111.54 | |
| J3490 | Unclassified drugs | <1% | 2,855 | $47.83 |
| OP250 | <1% | 26,739 | $44.14 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 293 | $7.77 |
| A6216 | Gauze, non-impregnated, non-sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | <1% | 6,503 | $2.00 |
| 90662 | 0% | 13 | $0.00 | |
| 90661 | 0% | 19 | $0.00 | |
| 90682 | 0% | 40 | $0.00 | |
| 0002A | 0% | 16 | $0.00 | |
| 0001A | 0% | 24 | $0.00 | |
| 84132 | 0% | 623 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 261 | $0.00 |
| 86704 | 0% | 12 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 25 | $0.00 |
| 90686 | 0% | 84 | $0.00 | |
| 0064A | 0% | 13 | $0.00 | |
| 90732 | 0% | 27 | $0.00 | |
| 90688 | 0% | 14 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 0% | 27 | $0.00 |
| 86580 | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.